JAZZ Stock Analysis: Buy, Sell, or Hold?
JAZZ - Jazz Pharmaceuticals, Inc.
$232.33
4.49 (1.97%)
▲
5d:
+1.65%
30d:
+15.55%
90d:
+39.76%
HOLD
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
JAZZ is down 3.4% this week, but smart money is accumulating calls. Top strike: $220 2026-06-18 with 322 OI. Call ratio: 94% View Scanner →
Strength: 6.1/10
Get Alerted When JAZZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called JAZZ this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: JAZZ trades at premium valuation expecting 5.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: JAZZ trades at premium valuation expecting 5.6% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$382.53
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$237.52
2.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: JAZZ is currently trading at $232.33, which is considered extended relative to its 30-day fair value range of $193.32 to $218.09. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.1) compared to its historical average (7.7). At these levels, the market is pricing in 5.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, JAZZ is in a strong uptrend. The price is approaching resistance at $235.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: JAZZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, JAZZ is in a strong uptrend. The price is approaching resistance at $235.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: JAZZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$193.32 -
$218.09
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.7%
Protect Your Profits
JAZZ is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.5% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($241.76)
- BEARISH: Market expects 5.6% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$193.32 -
$218.09
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$11.19
(4.8%)
Support & Resistance Levels
Support Level
$201.01
Resistance Level
$235.00
Current Trend
Strong Uptrend
Technical data as of
May 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.11
Wall Street Target
$241.76
(+4.1%)
Revenue Growth (YoY)
19.1%
Earnings Growth (YoY)
3.2%
Profit Margin
0.7%
Valuation Premium vs History
+5.6% premium
PE vs Historical
9.1 vs 7.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.6%
(market-implied from PE analysis)
1-Year Target
$245.34
(+6%)
2-Year Target
$259.08
(+12%)
3-Year Target
$273.59
(+18%)
3-Yr Target (if PE normalizes)
(PE: 9→8)
PE COMPRESSION
$231.32
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 77.4%)
$575.42
(+148%)
Base:
(SPY PE: 9.1, Growth: 77.4%)
$237.77
(+2%)
Bear:
(PE: 7.7, Growth: 77.4%)
$201.03
(-14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Forward PE: 12.32 | Forward EPS (Implied): $18.87
Bull Case
$280.54
(+21%)
Analyst growth 15.0%, PE expands to 12.9
Base Case
$232.33
(0%)
Market implied 0.0%, PE stable at 12.3
Bear Case
$177.73
(-24%)
Severe decline -15.0%, PE contracts to 11.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 14, 2026 9:46 AM ET
Data refreshes hourly during market hours. Next update: 10:46 AM
Data refreshes hourly during market hours. Next update: 10:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JAZZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Bruce C Cozadd
SELL
6000 shares
2026-04-01
Patricia Carr
SELL
1287 shares
2026-03-09
Norbert G Riedel
SELL
3415 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 60 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 63 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$127 | 59 HOLD |
Advanced JAZZ Option Strategies
Professional options setups generated by AI based on today's JAZZ price and gamma walls.
